Revelstoke invests in specialty infusion provider AOM Infusion

AOM Infusion provides patients with intravenous immunoglobulin biologics and other therapies.

15 April 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.